SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-18-030262
Filing Date
2018-05-03
Accepted
2018-05-03 16:19:07
Documents
61
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a18-8611_110q.htm 10-Q 949571
2 EX-10.2 a18-8611_1ex10d2.htm EX-10.2 83067
3 EX-10.3 a18-8611_1ex10d3.htm EX-10.3 45675
4 EX-31.1 a18-8611_1ex31d1.htm EX-31.1 11658
5 EX-31.2 a18-8611_1ex31d2.htm EX-31.2 11573
6 EX-32.1 a18-8611_1ex32d1.htm EX-32.1 10656
13 GRAPHIC g86111kwi001.jpg GRAPHIC 5655
14 GRAPHIC g86111kwi002.jpg GRAPHIC 101028
15 GRAPHIC g86111kwi003.jpg GRAPHIC 5546
  Complete submission text file 0001104659-18-030262.txt   4189521

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT crvs-20180331.xml EX-101.INS 776299
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crvs-20180331.xsd EX-101.SCH 34195
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT crvs-20180331_cal.xml EX-101.CAL 45176
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT crvs-20180331_def.xml EX-101.DEF 90179
11 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT crvs-20180331_lab.xml EX-101.LAB 313942
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crvs-20180331_pre.xml EX-101.PRE 214422
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

IRS No.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37719 | Film No.: 18804051
SIC: 2834 Pharmaceutical Preparations